image
Healthcare - Biotechnology - NASDAQ - US
$ 19.0
-5.8 %
$ 578 M
Market Cap
-3.23
P/E
BALANCE SHEET
452 M ASSETS
-25.88%
364 M LIABILITIES
4.60%
88.1 M EQUITY
-66.39%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition AnaptysBio, Inc.
image
Current Assets 407 M
Cash & Short-Term Investments 391 M
Receivables 6.85 M
Other Current Assets 9.08 M
Non-Current Assets 45.6 M
Long-Term Investments 27 M
PP&E 18.3 M
Other Non-Current Assets 256 K
Current Liabilities 37.4 M
Accounts Payable 4.7 M
Short-Term Debt 3.55 M
Other Current Liabilities 29.2 M
Non-Current Liabilities 327 M
Long-Term Debt 16 M
Other Non-Current Liabilities 311 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 36.0 71.3 495.7 250.5 171.0 113.6 81.2 51.2 51.7 22.2 2.8
Short Term Investments 354.9 369.9 52.4 143.2 203.2 313.5 167.2 0 0 0 0
Receivables 6.9 1.4 0.9 0 0 0.2 1.6 5.3 1.2 1.5 0
Inventory 0 1 1 0 0 0 0 1 0 0 0
Other Current Assets 9.1 4.5 4.9 5.8 7.0 7.0 2.7 1.6 1.1 1.5 0.2
Total Current Assets 406.8 447.2 553.9 396.6 377.7 434.2 252.7 58.2 53.5 24.4 3.1
PP&E 18.3 20.0 21.8 1.8 1.6 1.4 0.7 0.5 0.6 0.6 0.8
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 27.0 142.9 67.1 17.5 54.3 73.1 75.9 60 K 60 K 0 0
Other Long Term Assets 0.3 0.3 0.3 0.7 1.5 0.2 0.1 3.4 2.2 85 K 0.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 452.4 610.4 643.1 416.6 435.2 509.0 329.4 62.2 56.3 25.1 3.9
LIABILITIES
Accounts Payable 4.7 2.8 1.7 4.2 16.2 5.4 2.3 2.3 1.5 0.4 0.2
Short Term Debt 3.6 3.3 3.0 0.3 2.2 7.6 6.9 1 K 21 K 0.1 0.9
Other Current Liabilities 29.2 20.0 11.3 15.3 11.1 8.8 4.9 3.4 2.8 1.1 0.7
Total Current Liabilities 37.4 26.1 16.1 19.8 29.5 21.8 14.1 5.7 7.4 11.7 3.2
Long Term Debt 16.0 17.8 19.4 0 0.7 0.6 7.6 13.8 4.9 4.8 0
Deferred Tax Income 0 0 0 0 0 (0.2) (0.1) (0.2) (0.1) 0 0
Other Liabilities 310.8 304.4 251.1 0 0 0.2 0.1 3.4 1.7 0.6 0.6
Total Liabilities 364.3 348.3 286.6 19.8 30.2 22.6 21.8 22.9 13.9 19.1 3.8
EQUITY
Common Stock 27 K 29 K 28 K 27 K 27 K 27 K 24 K 3 K 3 K 17 K 17 K
Retained Earnings (614.1) (450.5) (321.8) (264.0) (244.0) (146.7) (85.0) (54.9) (50.7) (45.3) (48.8)
Other Accumulative Comprehensive Income/Loss (0.8) (5.2) (0.4) 4 K 0.3 (0.2) (0.4) (3.8) (3.6) (3.4) (3.1)
Total Equity 88.1 262.1 356.4 396.7 405.0 486.4 307.6 39.3 42.3 6.0 0.1
Total Liabilities and Equity 452.4 610.4 643.1 416.6 435.2 509.0 329.4 62.2 56.3 25.1 3.9
SHARES OUTSTANDING
Common Shares Outstanding 26.9 28.2 27.4 27.3 27.1 24.7 19.8 18.2 14.2 14.2 58.5